• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色氨酸、谷氨酰胺和天冬酰胺在癌症免疫治疗中的代谢——协同作用还是耐药机制?

Metabolism of Tryptophan, Glutamine, and Asparagine in Cancer Immunotherapy-Synergism or Mechanism of Resistance?

作者信息

Kiełbowski Kajetan, Bakinowska Estera, Becht Rafał, Pawlik Andrzej

机构信息

Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.

Department of Clinical Oncology, Chemotherapy and Cancer Immunotherapy, Pomeranian Medical University, 71-252 Szczecin, Poland.

出版信息

Metabolites. 2025 Feb 21;15(3):144. doi: 10.3390/metabo15030144.

DOI:10.3390/metabo15030144
PMID:40137109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11944271/
Abstract

Amino acids are crucial components of proteins, key molecules in cellular physiology and homeostasis. However, they are also involved in a variety of other mechanisms, such as energy homeostasis, nitrogen exchange, further synthesis of bioactive compounds, production of nucleotides, or activation of signaling pathways. Moreover, amino acids and their metabolites have immunoregulatory properties, significantly affecting the behavior of immune cells. Immunotherapy is one of the oncological treatment methods that improves cytotoxic properties of one's own immune system. Thus, enzymes catalyzing amino acid metabolism, together with metabolites themselves, can affect immune antitumor properties and responses to immunotherapy. In this review, we will discuss the involvement of tryptophan, glutamine, and asparagine metabolism in the behavior of immune cells targeted by immunotherapy and summarize results of the most recent investigations on the impact of amino acid metabolites on immunotherapy.

摘要

氨基酸是蛋白质的关键组成部分,而蛋白质是细胞生理学和体内平衡中的关键分子。然而,它们还参与多种其他机制,如能量平衡、氮交换、生物活性化合物的进一步合成、核苷酸的产生或信号通路的激活。此外,氨基酸及其代谢产物具有免疫调节特性,显著影响免疫细胞的行为。免疫疗法是改善自身免疫系统细胞毒性特性的肿瘤治疗方法之一。因此,催化氨基酸代谢的酶以及代谢产物本身可影响免疫抗肿瘤特性和对免疫疗法的反应。在本综述中,我们将讨论色氨酸、谷氨酰胺和天冬酰胺代谢在免疫疗法靶向的免疫细胞行为中的作用,并总结关于氨基酸代谢产物对免疫疗法影响的最新研究结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/d0fa0199396c/metabolites-15-00144-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/735a6feb994a/metabolites-15-00144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/c19d7ccbcdc1/metabolites-15-00144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/10794d7d1d57/metabolites-15-00144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/c3b1b27e4ef0/metabolites-15-00144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/2429ae14261b/metabolites-15-00144-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/d0fa0199396c/metabolites-15-00144-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/735a6feb994a/metabolites-15-00144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/c19d7ccbcdc1/metabolites-15-00144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/10794d7d1d57/metabolites-15-00144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/c3b1b27e4ef0/metabolites-15-00144-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/2429ae14261b/metabolites-15-00144-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d096/11944271/d0fa0199396c/metabolites-15-00144-g006.jpg

相似文献

1
Metabolism of Tryptophan, Glutamine, and Asparagine in Cancer Immunotherapy-Synergism or Mechanism of Resistance?色氨酸、谷氨酰胺和天冬酰胺在癌症免疫治疗中的代谢——协同作用还是耐药机制?
Metabolites. 2025 Feb 21;15(3):144. doi: 10.3390/metabo15030144.
2
A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.谷氨酰胺和天冬酰胺γ-氮在被致癌病毒劫持的癌细胞核苷酸生物合成中的关键作用
mBio. 2017 Aug 15;8(4):e01179-17. doi: 10.1128/mBio.01179-17.
3
Stable isotope studies reveal pathways for the incorporation of non-essential amino acids in Acyrthosiphon pisum (pea aphids).稳定同位素研究揭示了豌豆蚜(豆蚜)中非必需氨基酸的掺入途径。
J Exp Biol. 2015 Dec;218(Pt 23):3797-806. doi: 10.1242/jeb.129189.
4
Targeting amino acid-metabolizing enzymes for cancer immunotherapy.针对氨基酸代谢酶的癌症免疫疗法。
Front Immunol. 2024 Aug 14;15:1440269. doi: 10.3389/fimmu.2024.1440269. eCollection 2024.
5
Enhancing Leukemia Treatment: The Role of Combined Therapies Based on Amino Acid Starvation.增强白血病治疗效果:基于氨基酸饥饿的联合疗法的作用
Cancers (Basel). 2024 Mar 16;16(6):1171. doi: 10.3390/cancers16061171.
6
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor.天冬酰胺通过作为氨基酸交换因子来促进癌细胞增殖。
Nat Commun. 2016 Apr 29;7:11457. doi: 10.1038/ncomms11457.
7
Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity.谷氨酰胺的代谢重编程与肿瘤发生、多药耐药及肿瘤免疫相关。
Eur J Pharmacol. 2023 Feb 5;940:175323. doi: 10.1016/j.ejphar.2022.175323. Epub 2022 Dec 17.
8
Targeting pivotal amino acids metabolism for treatment of leukemia.靶向关键氨基酸代谢用于白血病治疗。
Heliyon. 2024 Nov 16;10(23):e40492. doi: 10.1016/j.heliyon.2024.e40492. eCollection 2024 Dec 15.
9
[Integrative transcriptomics-metabolomics approach to identify metabolic pathways regulated by glutamine synthetase activity].[采用整合转录组学-代谢组学方法鉴定由谷氨酰胺合成酶活性调控的代谢途径]
Se Pu. 2025 Mar;43(3):207-219. doi: 10.3724/SP.J.1123.2024.04003.
10
Metabolite and light regulation of metabolism in plants: lessons from the study of a single biochemical pathway.植物中代谢物与代谢的光调节:来自单一生化途径研究的经验教训
Braz J Med Biol Res. 2001 May;34(5):567-75. doi: 10.1590/s0100-879x2001000500003.

本文引用的文献

1
Discovery of highly active kynureninases for cancer immunotherapy through protein language model.通过蛋白质语言模型发现用于癌症免疫治疗的高活性犬尿氨酸酶
Nucleic Acids Res. 2025 Jan 7;53(1). doi: 10.1093/nar/gkae1245.
2
NEK8 promotes the progression of gastric cancer by reprogramming asparagine metabolism.NEK8通过重编程天冬酰胺代谢促进胃癌进展。
Mol Med. 2025 Jan 6;31(1):3. doi: 10.1186/s10020-024-01062-9.
3
Asparagine endopeptidase regulates lysosome homeostasis via modulating endomembrane phosphoinositide composition.天冬酰胺内肽酶通过调节内膜磷酸肌醇组成来调控溶酶体稳态。
Cell Death Dis. 2025 Jan 2;15(12):883. doi: 10.1038/s41419-024-07187-3.
4
IDO1-mediated M2 macrophage polarization alleviates the progression of ankylosing spondylitis.吲哚胺 2,3-双加氧酶 1(IDO1)介导的 M2 巨噬细胞极化减轻强直性脊柱炎的进展。
Autoimmunity. 2025 Dec;58(1):2441134. doi: 10.1080/08916934.2024.2441134. Epub 2024 Dec 18.
5
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined with Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies.吲哚胺2,3-双加氧酶1抑制剂甲磺酸林罗司他联合纳武单抗或纳武单抗与伊匹木单抗治疗晚期实体瘤或血液系统恶性肿瘤的1/2期研究。
Clin Cancer Res. 2025 Jun 3;31(11):2134-2144. doi: 10.1158/1078-0432.CCR-24-0439.
6
IDO1 inhibitors are synergistic with CXCL10 agonists in inhibiting colon cancer growth.IDO1 抑制剂与 CXCL10 激动剂协同抑制结肠癌生长。
Biomed Pharmacother. 2024 Oct;179:117412. doi: 10.1016/j.biopha.2024.117412. Epub 2024 Sep 9.
7
An ultra-long-acting L-asparaginase synergizes with an immune checkpoint inhibitor in starvation-immunotherapy of metastatic solid tumors.超长效 L-天冬酰胺酶与免疫检查点抑制剂协同作用于转移性实体瘤的饥饿免疫治疗。
Biomaterials. 2025 Jan;312:122740. doi: 10.1016/j.biomaterials.2024.122740. Epub 2024 Jul 31.
8
Successful Treatment of Cutaneous Squamous Cell Cancer with Cemiplimab-A Report of Two Cases Demonstrating the Management of Pseudoprogression and Adverse Events.西米普利单抗成功治疗皮肤鳞状细胞癌——两例病例报告,展示假性进展和不良事件的处理
J Clin Med. 2024 Jul 19;13(14):4236. doi: 10.3390/jcm13144236.
9
Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study.派姆单抗联合依帕卡司他或安慰剂用于顺铂不耐受的尿路上皮癌:ECHO-307/KEYNOTE-672 研究结果。
BMC Cancer. 2024 Jul 25;23(Suppl 1):1252. doi: 10.1186/s12885-023-10727-3.
10
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study.依匹单抗联合帕博利珠单抗对比安慰剂联合帕博利珠单抗用于晚期尿路上皮癌:ECHO-303/KEYNOTE-698 研究的随机 III 期结果。
BMC Cancer. 2024 Jul 25;23(Suppl 1):1256. doi: 10.1186/s12885-023-11213-6.